Hubbry Logo
TetrazoleTetrazoleMain
Open search
Tetrazole
Community hub
Tetrazole
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Tetrazole
Tetrazole
Tetrazole
View on Wikipedia
from Wikipedia
1H-Tetrazole
Identifiers
3D model (JSmol)
ChEBI
ChemSpider
ECHA InfoCard 100.005.477 Edit this at Wikidata
UNII
  • InChI=1S/CH2N4/c1-2-4-5-3-1/h1H,(H,2,3,4,5) checkY
    Key: KJUGUADJHNHALS-UHFFFAOYSA-N checkY
  • InChI=1/CH2N4/c1-2-4-5-3-1/h1H,(H,2,3,4,5)
    Key: KJUGUADJHNHALS-UHFFFAOYAI
  • InChI=1S/CH2N4/c1-2-4-5-3-1/h1H,(H,2,3,4,5)
    Key: KJUGUADJHNHALS-UHFFFAOYSA-N
  • [nH]1nnnc1
Properties
CH2N4
Molar mass 70.05 g/mol
Density 1.477 g/mL
Melting point 157 to 158 °C (315 to 316 °F; 430 to 431 K)[2]
Boiling point 220 ± 23 °C (428 ± 41 °F; 493 ± 23 K)
Acidity (pKa) 4.90[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

A tetrazole is a synthetic organic heterocyclic compound, consisting of a 5-member ring of four nitrogen atoms and one carbon atom. The name tetrazole also refers to the parent compound - a whitish crystalline powder with the formula CH2N4, of which three isomers exist.

Structure and bonding

[edit]

Three isomers of the parent tetrazole exist, differing in the position of the double bonds: 1H-, 2H-, and 5H-tetrazole. The 1H- and 2H- isomers are tautomers, with the equilibrium lying on the side of 1H-tetrazole in the solid phase.[3][4][5] In the gas phase, 2H-tetrazole dominates.[4][6][7] These isomers can be regarded as aromatic, with 6 π-electrons, while the 5H-isomer is nonaromatic.

Tautomerization of the 1H-tetrazole (left) and 2H-tetrazole (middle) aromatic isomers in comparison with the nonaromatic 5H-tetrazole (right)

Phosphorus analogs do not have the same electronic nature, with 1H-tetraphosphole having a more pyramidal geometry of the phosphorus at position 1. Instead, it is the anionic tetraphospholides that are aromatic.[8]

Strongly inductively electron-withdrawing functional groups attached to a tetrazole may stabilize a tautomeric ring-opening equilibrium with an azidoimine form.[9]

Synthesis

[edit]

1H-Tetrazole was first prepared by the reaction of anhydrous hydrazoic acid and hydrogen cyanide under pressure. A Pinner reaction of organic nitriles with sodium azide in the presence of a buffered strong acid (e.g. triethylammonium chloride) synthesizes 5-substituted 1H-tetrazoles cleanly.[10] Another method is the deamination of 5-aminotetrazole, which can be commercially obtained or prepared in turn from aminoguanidine.[11][12]

2-Aryl-2H-tetrazoles are synthesized by a [3+2] cycloaddition reaction between an aryl diazonium and trimethylsilyldiazomethane.[13]

Uses

[edit]

There are several pharmaceutical agents which are tetrazoles, including several cephalosporin-class antibiotics. Tetrazoles can act as bioisosteres for carboxylate groups because they have similar pKa and are deprotonated at physiological pH. Angiotensin II receptor blockers — such as losartan and candesartan, often are tetrazoles. A well-known tetrazole is dimethyl thiazolyl diphenyl tetrazolium bromide (MTT). This tetrazole is used in the MTT assay to quantify the respiratory activity of live cells culture, although it generally kills the cells in the process. Some tetrazoles can also be used in DNA assays.[14] Studies suggest VT-1161 and VT-1129 are a potential potent antifungal drugs as they disturbs fungal enzymatic function but not human enzymes.[15][16]

Some tetrazole derivatives with high energy have been investigated as high performance explosives as a replacement for TNT and also for use in high performance solid rocket propellant formulations.[17][18] These include the azidotetrazolate salts of nitrogen bases.

Other tetrazoles are used for their explosive or combustive properties, such as tetrazole itself and 5-aminotetrazole, which are sometimes used as a component of gas generators in automobile airbags. Tetrazole based energetic materials produce high-temperature, non-toxic reaction products such as water and nitrogen gas,[19] and have a high burn rate and relative stability,[20] all of which are desirable properties. The delocalization energy in tetrazole is 209 kJ/mol.

1H-Tetrazole and 5-(benzylthio)-1H-tetrazole (BTT) are widely used as acidic activators of the coupling reaction in oligonucleotide synthesis.[21]

C,N substituted tetrazoles can undergo controlled thermal decomposition to form highly reactive nitrilimines.[22][23] These can in turn undergo a variety of 1,3-dipolar cycloaddition reactions.[24]

Scheme 2. Nitrilimine formation
Scheme 2. Nitrilimine formation
[edit]

References

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Tetrazole

View on Grokipedia
from Grokipedia
Tetrazoles are a class of synthetic organic heterocyclic compounds characterized by a planar, five-membered ring consisting of one carbon atom and four adjacent atoms, with the parent compound 1H-tetrazole having the molecular formula CH₂N₄ and existing primarily in 1H- and 2H-tautomeric forms. These compounds exhibit high content (approximately 80% by weight in the unsubstituted form), conferring unique physicochemical properties such as , thermal stability up to around 155–157 °C, and resistance to and bases, though they can be shock-sensitive explosives comparable in energy to TNT due to rapid decomposition releasing oxides. The parent tetrazole is a weak with a pKa of 4.9, enabling formation of stable anions (tetrazolides) or cations (tetrazolium ions) depending on substitution, and it displays moderate in (about 23 g/100 mL at 20 °C) while appearing as an odorless white to light-yellow crystalline powder. Tetrazoles are commonly synthesized through [3+2] cycloaddition reactions between nitriles and or azide sources like (NaN₃), often catalyzed by ionic liquids or metals for improved yields, a method that has been refined since their discovery in 1885. In applications, tetrazoles serve as versatile scaffolds in , acting as bioisosteres for carboxylic acids and cis-amide bonds to enhance metabolic stability, lipophilicity, and receptor binding; over 20 FDA-approved drugs incorporate tetrazole moieties, including the losartan for treatment and various antimicrobials, antiallergics, and hormonal agents. Beyond pharmaceuticals, they find use in biochemistry for and as ligands in metal complexes for and imaging, as well as in energetic materials and explosives due to their high density facilitating hydrogen bonding, π-stacking, and properties.

Structure and properties

Molecular structure and tautomerism

Tetrazole is a five-membered with the molecular formula \ceCH2N4\ce{CH2N4}, comprising one carbon atom at position 5 and four adjacent atoms at positions 1–4 in the ring. The parent includes a bonded to the carbon and another to one of the nitrogens, enabling tautomerism. This compound exhibits three tautomeric isomers: 1H-tetrazole, with the labile on N1 (directly adjacent to C5); 2H-tetrazole, featuring the on N2; and 5H-tetrazole, a non-aromatic variant that is significantly less stable. The 1H- and 2H-forms represent the predominant tautomers, differing primarily in the position of the and the placement of double bonds within the ring. In the 1H-form, a common Kekulé representation is \ceH−N1−N2=N3−N4=C5−H\ce{H-N1-N2=N3-N4=C5-H}, while the 2H-form shifts to \ceN1=N2−N3(H)−N4=C5−H\ce{N1=N2-N3(H)-N4=C5-H}. The 5H-tautomer involves a akin to \ceN1−N2(H)−N3=N4−CH5\ce{N1-N2(H)-N3=N4-CH5}, lacking full conjugation and thus exhibiting reduced stability. These forms interconvert through 1,2-proton shifts, with delocalized electrons contributing to the ring's overall planarity. Tautomerism between the 1H- and 2H-isomers is influenced by environmental conditions. In the solid state and polar solutions, the 1H-tautomer dominates, stabilized by intermolecular hydrogen bonding that favors the position. In contrast, the gas phase prefers the 2H-tautomer due to intramolecular electronic effects. calculations reveal an energy difference of approximately 7 kJ/mol favoring 2H in the gas phase, but in polar media (dielectric constant ε ≈ 40), the 1H-form is more stable by about 12 kJ/mol, leading to an K (1H/2H) on the order of 10–20 in solution at . These differences arise from effects enhancing the polarity of the 1H-configuration. Experimental spectroscopic studies, including NMR and IR, confirm the prevalence of 1H in crystalline and solvated forms. The tautomeric isomers of tetrazole were first discovered by Swedish chemist Johan A. Bladin in 1885 during his synthesis of the parent compound and derivatives from cyano compounds and precursors. Bladin's work established the ring connectivity and noted the potential for isomeric forms, laying the foundation for later structural elucidations via and computational modeling. Line diagrams and Kekulé structures remain standard for depicting these tautomers, often highlighting the delocalized π-system with dashed lines or resonance arrows to convey electron sharing among the nitrogen atoms.

Bonding and aromaticity

The 1H- and 2H-tetrazoles exhibit aromatic character, satisfying through a planar, cyclic, containing 6 π-electrons. In this arrangement, four π-electrons arise from two double bonds within the ring, while the remaining two are contributed by the on the pyrrole-like atom, analogous to the aromatic stabilization in , another five-membered heterocycle with 6 π-electrons. This delocalization is evidenced by bond lengths that deviate from localized single and double bonds, with C–N bonds averaging approximately 1.35 Å and N–N bonds around 1.38 Å, indicating partial double-bond character throughout the ring. of 1H-tetrazole shows C-N bond lengths of 1.327–1.368 Å and N-N bonds of 1.346–1.370 Å, confirming the delocalized structure. The electron density distribution in tetrazole further underscores its aromatic stability and reactivity. Computational analyses reveal high negative charge accumulation on and N4, which facilitates and contributes to the compound's acidity, with the pKa of 1H-tetrazole measured at 4.9, comparable to that of carboxylic acids due to the resonance-stabilized tetrazolate anion. In contrast, the 5H-tetrazole lacks this aromatic delocalization, featuring localized bonds and an estimated energy 82–120 kJ/mol higher than the 1H- or 2H-forms, rendering it unstable and rarely observed. Spectroscopic data provide empirical support for these bonding characteristics. In ¹H NMR spectra, the NH proton of 1H-tetrazole appears as a broad singlet around 16 ppm in DMSO-d₆, reflecting its involvement in the aromatic π-system and hydrogen bonding. Infrared spectroscopy reveals characteristic ring vibrations, including C=N stretches near 1550 cm⁻¹ and broader tetrazole ring absorptions between 1340–1640 cm⁻¹, consistent with the delocalized electron density.

Physical and chemical properties

1H-Tetrazole is an odorless white to light-yellow crystalline powder. It has a of 155–157 °C and undergoes explosive upon heating above this . Its is 1.48 g/cm³. The compound exhibits moderate in (23 g/100 mL at 20 °C), high solubility in polar solvents such as DMSO, , , and acetone, and is insoluble in nonpolar solvents. As a , 1H-tetrazole behaves as a weak with a pKa of 4.9, enabling it to form salts upon reaction with bases. It demonstrates thermal stability under normal conditions but decomposes explosively at elevated s, releasing gas. The compound's shock sensitivity is lower than that of , though it remains hazardous under impact or friction. In terms of reactivity, of 1H-tetrazole occurs preferentially at the N1 position, yielding the tetrazolate anion. reactions typically favor substitution at the N2 position over N1, influenced by reaction conditions. Under strong acidic conditions, 1H-tetrazole can undergo ring opening to and . It also acts as an in processes. The explosive nature of 1H-tetrazole stems from its high content, with an N/C ratio of 4:1. Handling requires precautions such as avoiding contact with strong oxidizers, reducing agents, metals, and moisture, which can release toxic and oxides; additionally, certain metals should be avoided to prevent of formation.

Synthesis

Classical methods

The first tetrazole derivative, 5-phenyl-1H-tetrazole, was synthesized in 1885 by J. A. Bladin through the reaction of 1,2-dicyano-1-phenylhydrazine with , marking the discovery of the tetrazole ring system. This approach relied on the diazotization and cyclization of a precursor containing adjacent cyano groups, yielding the heterocycle after loss of . The unsubstituted 1H-tetrazole was first prepared in 1910 by O. Dimroth and G. Fester via the direct [3+2] of and under pressure, representing one of the earliest examples of azide-nitrile coupling. The simplified reaction proceeds as follows: \ceHCN+HN3−>[pressure]1H−tetrazole\ce{HCN + HN3 ->[pressure] 1H-tetrazole} This method highlights the fundamental reactivity of azides with nitriles but is limited by the extreme toxicity and explosiveness of , restricting its practical use. A cornerstone of classical tetrazole synthesis is the Huisgen [3+2] dipolar cycloaddition developed in the 1950s, which couples organic nitriles with sodium azide to form 5-substituted 1H-tetrazoles. Typically performed in acetic acid solvent at 80–100 °C with ammonium chloride as a catalyst to generate hydrazoic acid in situ, the reaction delivers yields of 70–90% and favors the 1H-tautomer at the 5-position. The general scheme is: \ce{R-C#N + NaN3 + NH4Cl ->[AcOH, 80-100°C] 5-R-1H-tetrazole + NaCl} This versatile route has been applied to a wide range of alkyl and aryl nitriles, establishing it as a standard laboratory method despite requiring careful handling of azide reagents. An alternative classical variant, known as the Pinner tetrazole synthesis, utilizes iminoester hydrochloride salts—prepared from nitriles via the Pinner reaction with alcohols and HCl—reacted with sodium azide to afford 5-substituted 1H-tetrazoles. This approach is particularly suited for nitriles sensitive to direct azide addition, proceeding under milder conditions through nucleophilic attack on the imidate carbon followed by cyclization and elimination. The process can be represented as: \ceR−C(OR′)=NH⋅HCl+NaN3−>5−R−1H−tetrazole+NaCl+R′OH\ce{R-C(OR')=NH \cdot HCl + NaN3 -> 5-R-1H-tetrazole + NaCl + R'OH} For the unsubstituted parent compound, a common route involves deamination of 5-amino-1H-tetrazole (itself obtained from cyanamide and sodium azide) using nitrous acid, which removes the amino group via diazotization and loss of nitrogen. This yields 1H-tetrazole in moderate efficiency but underscores the challenges of preparing the parent heterocycle without substituents. These early methods, while foundational, share limitations including the hazardous manipulation of hydrazoic acid derivatives, which are both toxic and potentially explosive, and occasional low in forming 1,5- versus 2,5-disubstituted products during of the initial cycloadducts.

Modern synthetic approaches

Modern synthetic approaches to tetrazoles have focused on improving efficiency, , and safety over classical methods, particularly by employing to mitigate the hazards associated with s and enable milder conditions. A prominent strategy involves copper-catalyzed [3+2] reactions between organic s (or trimethylsilyl azide, TMSN3) and nitriles, yielding 5-substituted 1H-tetrazoles or 1,5-disubstituted variants with high . For instance, the reaction of R-N3 with R'-CN in the presence of CuI or CuSO4 catalysts proceeds in solvents like DMF/MeOH at 60–100°C, affording products in 80–95% yields, as demonstrated in early developments that have since been optimized for broader substrate scope including aryl and alkyl nitriles. This approach contrasts with uncatalyzed thermal Huisgen s, which often produce mixtures but can favor 1,4-regioisomeric tetrazoles under high-temperature conditions without metal mediation. Metal-free multicomponent reactions (MCRs) have gained traction in the for their simplicity and avoidance of , particularly Ugi-type reactions involving amines, aldehydes or ketones, isonitriles, and azides or TMSN3. These one-pot processes generate 1,5-disubstituted tetrazoles directly, with examples using Fe3O4@SiO2 or base in green solvents like at , achieving 85–98% yields across diverse substrates. has emerged as another metal-free innovation for tetrazole synthesis under visible light, though applications remain niche as of 2024. Eco-friendly advancements prioritize sustainable solvents and catalysts, such as the 2025 meglumine-catalyzed [3+2] of aldehydes, , and in , delivering 5-substituted 1H-tetrazoles in 85–98% yields under with the sugar-derived catalyst recyclable up to five times. Biocatalytic methods, including enzymatic dynamic kinetic resolution, have been explored for pharmaceutical precursors like tetrazole esters, using lipases for enantioselective transformations in aqueous media, though direct ring formation remains challenging. For industrial scalability, continuous flow processes address azide safety concerns by minimizing reagent volumes and enabling real-time monitoring, as in 2021–2025 protocols using Cu or Co catalysts in microreactors for 1,5-disubstituted tetrazoles at throughputs up to 10 g/h with >90% yields and integrated . Regioselective access to 2H-tetrazoles is achieved via N-arylation of 1H-tetrazoles with diaryliodonium salts or arylboronic acids under Cu catalysis, such as Cu(OAc)2 in DMF at 80°C, providing 2-aryl-5-substituted products in 70–90% yields without . These methods enhance tetrazole utility in synthesis by offering precise control over substitution patterns.

Applications

In medicinal chemistry

Tetrazoles play a prominent role in as bioisosteres for carboxylic acids, offering a similar pKa (around 4.9–5.0), spatial dimensions, and hydrogen-bonding capabilities while providing superior (logP increase of ~0.5–1.0 units) and resistance to metabolic . This substitution enhances drug-like properties, including improved oral and reduced enzymatic degradation, making tetrazoles ideal for optimizing in various therapeutic areas. For instance, in blockers (ARBs), the tetrazole mimics the C-terminal of II, facilitating potent AT1 receptor antagonism without the instability of free acids. Prominent examples include losartan and irbesartan, both featuring a 5-substituted 1H-tetrazole linked to a scaffold. Losartan, the first ARB approved by the FDA in 1995, treats by competitively blocking angiotensin II at the AT1 receptor, with the tetrazole contributing essential acidity and binding interactions. Irbesartan, approved in 1997, similarly employs the tetrazole for AT1 blockade, effectively managing and delaying progression in patients. These drugs exemplify how tetrazole incorporation boosts metabolic stability (e.g., extension to 6–9 hours for losartan) and gastrointestinal absorption compared to analogs. In antimicrobial applications, tetrazoles enhance spectrum and stability; , a first-generation introduced in the 1970s, incorporates a 1H-tetrazol-1-ylacetyl at the 7-position, enabling broad bactericidal activity against Gram-positive and some Gram-negative pathogens by inhibiting synthesis, with the conferring resistance to hydrolysis by certain beta-lactamases. More recently, the tetrazole antifungal VT-1161 (oteseconazole) selectively inhibits fungal CYP51, disrupting with minimal human enzyme cross-reactivity ( >10 μM for human ). Approved by the FDA in 2022 for recurrent vulvovaginal candidiasis, it entered phase III trials by 2024 for broader candidiasis indications, showing an MIC of 2.0 ± 0.2 μg/mL against persister cells (determined via ). Tetrazoles also advance anticancer therapies and research tools. In 2025 investigations, tetrazole-tethered derivatives acted as c-Src inhibitors ( 302–410 nM), inducing in cell lines (e.g., 0.568 nM) through ROS elevation, mitochondrial depolarization, and G1-phase arrest, with low toxicity to normal cells. For ADMET optimization in (CNS) drugs, tetrazole scaffolds improve and blood-brain barrier permeability; a 2025 study on theophylline-tetrazole hybrids for reported potent AChE inhibition ( 15.68 μM) and favorable SwissADME profiles, including non-toxicity and high CNS exposure potential. In viability assays, tetrazolium salts like MTT—structurally related via their tetrazolium core—are reduced by viable cells to purple , enabling colorimetric quantification of proliferation and in screening (absorbance at 570 nm). Structure-activity relationships (SAR) for 5-aryl-tetrazoles as agents highlight substituent effects on the aryl ring; early studies on 3-(5-aryl-2-tetrazolyl)alkanoic acids showed that ortho- or meta-halogenation enhances potency in carrageenan-induced models, with derivatives outperforming indomethacin in COX inhibition (ED50 <50 mg/kg). Recent SAR refinements, including sulfanilamide-tetrazole conjugates, confirm that electron-withdrawing groups on the 5-aryl position boost COX-2 selectivity ( <1.5 μM) and reduce gastrointestinal side effects compared to traditional NSAIDs.

In explosives and materials

Tetrazoles are valued in high-energy applications due to their high nitrogen content of approximately 80% by weight, which facilitates the release of a large volume of nitrogen gas (N₂) upon decomposition, contributing to enhanced detonation performance. The parent 1H-tetrazole exhibits a positive heat of formation of +237 kJ/mol, underscoring its energetic potential. In explosives, 5-aminotetrazole serves as a key precursor for synthesizing high-nitrogen compounds such as 3,6-bis(1H-1,2,3,4-tetrazol-5-ylamino)-1,2,4,5-tetrazine (BTATz), which demonstrates a density of 1.76 g/cm³ and a detonation velocity of 7520 m/s. BTATz is employed in gas-generating compositions for airbags and as a primary explosive due to its balanced energy output and relative insensitivity. Tetrazole derivatives also find use in propellants, where salts like azotetrazolate provide low-signature fuels by minimizing visible smoke and environmental impact through predominant N₂ production. Recent 2024 advancements include N-rich triazole-tetrazole hybrids, such as those in the N3 series, designed for ; these exhibit velocities exceeding 9300 m/s, corresponding to pressures over 30 GPa, while maintaining high stability. Beyond energetics, tetrazoles act as ligands in metal-organic frameworks (MOFs) for gas storage applications, leveraging their multiple nitrogen donor sites for high coordination and porosity. For instance, polytetrazolate-based MOFs achieve capacities up to 1.89 wt% at moderate pressures, attributed to the abundance of open N-donor sites. Additionally, energetic polymers incorporating tetrazole units, such as 5-aminotetrazole-based variants, offer thermal stability exceeding 250 °C, enabling robust performance in advanced composite materials. Safety profiles of tetrazole salts are favorable, generally less impact-sensitive than conventional explosives like PETN (h₅₀ ≈ 35 cm in BAM fallhammer tests)—and onsets around 220 °C, reducing handling risks compared to conventional nitro explosives.

Other applications

Tetrazoles play a significant role in coordination chemistry, where deprotonated tetrazolate anions serve as multidentate ligands capable of binding metal ions through their atoms, forming stable complexes with transition metals such as and . For instance, tetrazolate-based ligands have been incorporated into (II) and (II) coordination polymers that exhibit catalytic activity in reactions like oxidation and processes. These complexes leverage the tetrazolate's ability to adopt various coordination modes, including monodentate and bidentate, enhancing their utility in homogeneous and . In oligonucleotide synthesis, tetrazole derivatives function as efficient coupling activators in the phosphoramidite method, protonating the phosphoramidite nitrogen to facilitate nucleophilic attack by the growing chain's hydroxyl group. Specifically, 1H-tetrazole is widely used as an activator due to its mild acidity and solubility, enabling high-yield assembly of DNA and RNA sequences on solid supports. Tetrazolium salts represent a key application in , particularly in cell viability assays. Compounds like 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) are colorless tetrazolium salts reduced by cellular dehydrogenases in viable cells to insoluble purple (for MTT) or water-soluble orange (for XTT). This bioreduction occurs via hydride transfer from NAD(P)H-dependent enzymes, allowing quantification of or through measurements, typically at 570 nm for MTT formazan. In agriculture, tetrazole derivatives have emerged as components of herbicides, pesticides, and fungicides, with 1,5-disubstituted tetrazoles showing promise as antifungal agents by inhibiting sterol biosynthesis in phytopathogenic fungi. For example, certain 1,5-disubstituted tetrazoles exhibit bioactivity against fungi such as Fusarium oxysporum, disrupting ergosterol production essential for fungal membrane integrity. Recent patents highlight their use in fungicidal compositions, often combined with other heterocycles to enhance efficacy and reduce plant damage. Tetrazoles find niche applications in dyes and , where they act as sensitizers and stabilizers in photographic emulsions. Tetrazole-containing polymers serve as antifoggants, preventing unwanted fogging during development, while certain derivatives enhance light sensitivity in imaging materials. In chemistry, tetrazole-based compounds function as co-sensitizers in dye-sensitized solar cells, improving injection and stability by anchoring to surfaces like TiO₂. Recent advancements include the use of tetrazoles as additives in lithium-sulfur batteries, where nitrogen-rich tetrazoles like 5-mercapto-1-methyltetrazole promote stable solid- interphases, suppress shuttling, and enhance cycling stability. Environmentally, tetrazole-functionalized materials aid in wastewater remediation through metal , with fibers modified with tetrazole groups selectively adsorbing such as lead and from contaminated water. These adsorbents exploit the tetrazolate's high affinity for metal ions via coordination, achieving removal efficiencies over 90% under neutral conditions, facilitating reuse in industrial effluent treatment.

Substituted tetrazoles

Substituted tetrazoles are derived from the parent 1H-tetrazole core through modifications at the 5-position or nitrogen atoms, altering their reactivity, stability, and applications. 5-Substituted 1H-tetrazoles, such as 5-phenyl-1H-tetrazole, are commonly synthesized via the [3+2] cycloaddition of nitriles like benzonitrile with sodium azide or trimethylsilyl azide under copper catalysis, yielding products in good to high efficiency. These derivatives exhibit enhanced thermal and chemical stability compared to the unsubstituted form, remaining intact across a broad pH range and resistant to oxidizing or reducing agents. In coordination chemistry, they serve as versatile ligands due to the multiple nitrogen donor sites, facilitating the formation of metal complexes with tunable structural properties like porosity and solvent resistance. 1,5-Disubstituted tetrazoles are prepared through regioselective methods, including the Ugi- reaction followed by copper-catalyzed -alkyne cycloaddition (CuAAC), which allows precise placement of substituents. For instance, 1-benzyl-5-methyl-1H-tetrazole can be accessed via addition to imines derived from and , followed by cyclization. Recent advances in 2024 have emphasized asymmetric synthesis, preserving from precursors like in electrocyclic closures of imino- intermediates, enabling enantioselective production for bioactive applications. These compounds display high in N-substitution, influenced by the 5-substituent's electronic effects, favoring 1,5-over 2,5-isomers in reactions. Amino and nitro derivatives represent key functionalized tetrazoles with specialized properties. 5-Aminotetrazole, prepared from aminoguanidine and , acts as a nitrogen-rich precursor for energetic materials, decomposing at approximately 201 °C and forming sensitive explosive salts upon metal coordination. Tetrazole-5-thiol derivatives, such as 1-phenyl-1H-tetrazole-5-thiol, are utilized in for capping nanoparticles, enhancing their activity and stability in matrices or coordination frameworks. Developments in 2024–2025 have introduced bifunctional tetrazoles for advanced , where photoinduced reactions between tetrazole and primary amines yield 1,2,4-triazole cyclization products, enabling selective protein labeling without metal catalysts. In energetic materials, guanidinium 5,5'-azotetrazolate emerges as a high-nitrogen salt with calculated detonation velocities around 8500–9200 m/s, offering improved stability (decomposition at 239 °C) and reduced sensitivity compared to traditional explosives. Substituent effects significantly modulate tetrazole properties, particularly acidity and substitution patterns. Electron-withdrawing groups at the 5-position, such as nitro or trifluoromethyl, lower the pKa from the parent value of 4.9 significantly; for example, the 5-nitro derivative has a pKa of approximately -0.8, and the 5-(trifluoromethyl) derivative has a pKa of approximately 2.3. This shift promotes regioselective N-alkylation at the 1-position, as the deprotonated anion directs electrophiles away from electron-deficient sites.

Analogous heterocycles

Tetrazole, a five-membered heterocycle with four atoms and one carbon atom (4N:1C), shares structural similarities with other nitrogen-rich azoles but exhibits distinct properties due to its high content. In comparison, 1,2,3-triazole features three atoms and two carbon atoms (3N:2C), rendering it less acidic with a pKa of approximately 9.4, akin to , whereas tetrazole's pKa is around 4.9, comparable to carboxylic acids. This heightened acidity in tetrazole arises from the greater electron-withdrawing effect of the additional , facilitating at the N-H site. Functionally, 1,2,3-triazoles are prominent in copper-catalyzed azide-alkyne cycloaddition () for , but their lower density results in reduced energy content and explosivity relative to tetrazoles, which offer higher heat of formation for energetic materials applications. Imidazoles and pyrazoles, both containing two nitrogen atoms in a five-membered ring (2N:3C) with additional C-H groups, maintain through 6π-electron systems but possess fewer coordination sites and lower nitrogen content than tetrazole. The presence of C-H bonds in these heterocycles contributes to greater stability under oxidative conditions, yet tetrazole's elevated nitrogen proportion enhances its explosivity via more N-N bonds and increases its utility as a multidentate in coordination chemistry, where it can bind metals through multiple nitrogen donors. For instance, tetrazoles form stable complexes with transition metals, outperforming imidazoles and pyrazoles in high-nitrogen energetic coordination polymers due to their denser packing and higher velocities. Pentazole, a hypothetical all-nitrogen five-membered ring (5N:0C), represents an extreme in richness but contrasts sharply with tetrazole's stability; it decomposes explosively above -20°C, often via ring opening to and N₂, limiting its isolation to fleeting intermediates. Early synthesis attempts, such as the 1958 preparation of phenylpentazole from diazonium salts and , yielded unstable aryl derivatives that required cryogenic conditions for characterization, with decomposition rates exceeding 10⁴ s⁻¹ at . Subsequent efforts in the 2000s–2010s using metal coordination (e.g., or complexes) or electron-donating substituents like p-dimethylamino provided transient stability, but remains non-isolable in pure form, unlike the kinetically stable tetrazole, which benefits from partial aromatic delocalization and C-N bonding. Phosphorus analogs of tetrazole, such as 1H-tetraphosphole (replacing the carbon with in a P₄C framework), deviate from due to the pyramidal at , resulting in non-planar, less stable rings compared to tetrazole's planar structure. These compounds exhibit altered reactivity, with P-H bonds showing pKa values higher than analogous N-H in azoles (e.g., ~30–40 vs. tetrazole's 4.9), driven by 's lower . Recent theoretical studies in the 2020s have explored their acid-base properties and potential in organophosphorus synthesis, highlighting reactivity in and coordination, though practical applications remain niche due to synthetic challenges and reduced stability. In pharmaceutical contexts, tetrazole's role as a bioisostere for carboxylic acids surpasses that of tetrazine—a six-membered ring with four nitrogens—owing to tetrazole's greater metabolic stability and resistance to reduction; tetrazines undergo facile or reduction in biological media, potentially disrupting , while tetrazoles maintain integrity across ranges and resist enzymatic cleavage. This stability enables tetrazoles to enhance and binding affinity in scaffolds without the lability that limits tetrazines to transient bioorthogonal labeling rather than long-term therapeutics.

References

  1. https://pubchem.ncbi.nlm.nih.gov/compound/1H-Tetrazole
  2. https://www.sciencedirect.com/topics/chemistry/tetrazole
  3. https://pubs.acs.org/doi/10.1021/acs.chemrev.8b00564
  4. https://pubs.acs.org/doi/10.1021/ja00059a048
  5. https://pubs.aip.org/aip/jcp/article/140/6/064306/194122/Tetrazole-acetic-acid-Tautomers-conformers-and
  6. https://pubs.acs.org/doi/10.1021/jo010062n
  7. http://www.iosrjournals.org/iosr-jac/papers/vol8-issue2/Version-2/K08226376.pdf
  8. https://pmc.ncbi.nlm.nih.gov/articles/PMC10742751/
  9. https://pubs.rsc.org/en/content/getauthorversionpdf/C4RA03515A
  10. https://www.sciencedirect.com/science/article/abs/pii/S016612809900161X
  11. https://www.growingscience.com/ccl/Vol3/ccl_2014_1.pdf
  12. https://www.pnrjournal.com/index.php/home/article/download/5537/8235/7834
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC6376451/
  14. https://pubs.acs.org/doi/10.1021/ja0206644
  15. https://chemistry-europe.onlinelibrary.wiley.com/doi/abs/10.1002/ejoc.201200469
  16. https://www.thieme-connect.com/products/ejournals/pdf/10.1055/s-0037-1611863.pdf
  17. https://www.sciencedirect.com/science/article/pii/S0040403908003547
  18. https://www.sciencedirect.com/science/article/abs/pii/S0040402021004567
  19. https://pubs.acs.org/doi/10.1021/acsomega.4c02567
  20. https://www.tandfonline.com/doi/full/10.1080/00304948.2025.2550319
  21. https://pubmed.ncbi.nlm.nih.gov/38251869/
  22. https://onlinelibrary.wiley.com/doi/10.1002/asia.200800085
  23. https://www.sciencedirect.com/science/article/pii/S0223523424007517
  24. https://go.drugbank.com/drugs/DB00678
  25. https://go.drugbank.com/drugs/DB01029
  26. https://pubchem.ncbi.nlm.nih.gov/compound/Cefazolin
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC10887314/
  28. https://www.sciencedirect.com/science/article/abs/pii/S0045206825007242
  29. https://www.researchgate.net/publication/389550639_Discovery_of_novel_theophylline_derivatives_bearing_tetrazole_scaffold_for_the_treatment_of_Alzheimer%27s_disease
  30. https://www.sciencedirect.com/science/article/abs/pii/S0065128117304749
  31. https://pubmed.ncbi.nlm.nih.gov/5030919/
  32. https://webbook.nist.gov/cgi/cbook.cgi?ID=C288948&Mask=A
  33. https://www.researchgate.net/publication/26252286_Synthesis_and_characterization_of_36-bis1H-1234-tetrazol-5-ylamino-1245-tetrazine_BTATz_Novel_high-nitrogen_content_insensitive_high_energy_material
  34. https://www.tandfonline.com/doi/abs/10.1080/07370659808217508
  35. https://pubs.rsc.org/en/content/articlelanding/2024/ta/d4ta06447j
  36. https://www.mdpi.com/1996-1944/15/19/6936
  37. https://webbook.nist.gov/cgi/cbook.cgi?ID=C288948&Mask=1E9F
  38. https://www.sciencedirect.com/science/article/abs/pii/S0277538716302856
  39. https://pubs.rsc.org/en/content/articlehtml/2022/ra/d2ra04768c
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC8714388/
  41. https://pubs.acs.org/doi/10.1021/jo00316a020
  42. https://www.sciencedirect.com/science/article/abs/pii/S0040402013003360
  43. https://www.ncbi.nlm.nih.gov/books/NBK144065/
  44. https://www.thermofisher.com/us/en/home/life-science/cell-analysis/fluorescence-microplate-assays/microplate-assays-cell-viability/cyquant-xtt-mtt-assays-cell-viability.html
  45. https://pubs.acs.org/doi/10.1021/acs.jafc.5c06084
  46. https://patents.google.com/patent/WO2003016303A1/en
  47. https://patents.google.com/patent/US3576638A/en
  48. https://www.sciencedirect.com/science/article/abs/pii/S1566119920303542
  49. https://www.sciencedirect.com/science/article/abs/pii/S2095495622002224
  50. https://onlinelibrary.wiley.com/doi/abs/10.1002/app.35641
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC10801355/
  52. https://pubs.acs.org/doi/10.1021/jo201261w
  53. https://sciforum.net/manuscripts/5780/manuscript.pdf
  54. https://www.researchgate.net/publication/333221378_Synthesis_of_15-disubstituted_tetrazole-123_triazoles_hybrids_via_Ugi-azideCuAAC
  55. https://hal.science/hal-04667752v1/file/RESEARCH%252BPROGRESS%252BON%252BTETRAZOLE%252BDERIVATIVES%252B%25281%2529%252B%25282%2529%2520%25282%2529.pdf
  56. https://triggered.stanford.clockss.org/ServeContent?doi=10.3987%252Frev-00-530
  57. https://www.chemicalbook.com/ProductChemicalPropertiesCB7112166_EN.htm
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC9572200/
  59. https://pubs.acs.org/doi/abs/10.1021/jp205649y
  60. https://www.sciencedirect.com/science/article/abs/pii/S0277538714007682
  61. https://pubmed.ncbi.nlm.nih.gov/38190443/
  62. https://pubs.acs.org/doi/10.1021/acs.oprd.4c00364
  63. https://sciencemadness.org/scipics/tetrazoles(english).pdf
  64. https://www.guidechem.com/encyclopedia/es/5-trifluoromethyl-1h-tetrazole-dic434893.html
Add your contribution
Related Hubs
User Avatar
No comments yet.